Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble ACE2 as a potential therapy for COVID-19
Sudarshan Krishnamurthy, Richard F. Lockey, Narasaiah Kolliputi
AJP Cell Physiology (2021) Vol. 320, Iss. 3, pp. C279-C281
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Enzyme Therapy: Current Challenges and Future Perspectives
Miguel de la Fuente, Laura Lombardero, Alfonso Gómez-González, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9181-9181
Open Access | Times Cited: 123
Endotheliopathy in Acute COVID-19 and Long COVID
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8237-8237
Open Access | Times Cited: 33
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, et al.
European Journal of Internal Medicine (2021) Vol. 93, pp. 28-34
Open Access | Times Cited: 49
Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)
Alice G. Vassiliou, Alexandros Zacharis, Chrysi Keskinidou, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 695-695
Open Access | Times Cited: 38
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
Canhao Wu, Qin Xu, Huiyuan Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1523-1533
Open Access | Times Cited: 38
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
SARS-CoV-2 and the host-immune response
David P. Maison, Youping Deng, Mariana Gerschenson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities
Dipankar Gupta, Ashok Kumar, Avinash Singh Mandloi, et al.
Pharmacological Research (2021) Vol. 174, pp. 105924-105924
Closed Access | Times Cited: 26
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
Brian Dobosh, Keivan Zandi, Diego Moncada Giraldo, et al.
Cell Reports (2022) Vol. 39, Iss. 11, pp. 110945-110945
Open Access | Times Cited: 17
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
Christian Devaux, Laurence Camoin‐Jau
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 17
Population-specific polymorphisms and SARS-CoV-2 infectivity
Nikita Jain, Shampa Chatterjee
Elsevier eBooks (2025), pp. 75-87
Closed Access
Impact of COVID-19 on Individuals with Disabilities and Its Contribution to Causing Disabilities
Itsuro Kazama
(2025), pp. 1-13
Closed Access
Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2
Vignesh Mariappan, Pajanivel Ranganadin, S. Lokesh, et al.
Biochimie (2022) Vol. 201, pp. 139-147
Open Access | Times Cited: 15
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic
Hongyin Chen, Jiangyun Peng, Tengyao Wang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115370-115370
Open Access | Times Cited: 14
Navigating migraine care through the COVID-19 pandemic: an update
Heather Angus‐Leppan, Angelica E. Guiloff, Karen Benson, et al.
Journal of Neurology (2021) Vol. 268, Iss. 11, pp. 4388-4395
Open Access | Times Cited: 17
Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics
Vinayakumar Siragam, Mariam Maltseva, Nicolas Castonguay, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 2
Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries
Huang‐Ping Yu, Fu-Chao Liu, Yu-Kuo Chung, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4411-4437
Open Access | Times Cited: 2
Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review
Bhagat Singh, Dheer Singh, Vinod Verma, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 2, pp. 215-220
Open Access | Times Cited: 16
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2
Noelia Díaz‐Troyano, Pablo Gabriel-Medina, Stephen G. Weber, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 886-886
Open Access | Times Cited: 11
COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?
Claudio Gallo, Sirio Fiorino, Giovanni Posabella, et al.
Cytokine (2021) Vol. 148, pp. 155628-155628
Open Access | Times Cited: 14
Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2
Yasaman Nazerian, Kimia Vakili, Ali Ebrahimi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Moderate exercise may prevent the development of severe forms of COVID-19, whereas high-intensity exercise may result in the opposite
BA. Hagiu
Medical Hypotheses (2021) Vol. 157, pp. 110705-110705
Open Access | Times Cited: 13
Human Coronavirus Cell Receptors Provide Challenging Therapeutic Targets
Georgina I. López-Cortés, Miryam Palacios-Pérez, Margarita M. Hernández-Aguilar, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 174-174
Open Access | Times Cited: 5
Neutrophil elastase decreases SARS-CoV-2 spike protein binding to human bronchial epithelia by clipping ACE-2 ectodomain from the epithelial surface
Apparao B. Kummarapurugu, Adam M. Hawkridge, Jonathan Ma, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 6, pp. 104820-104820
Open Access | Times Cited: 5
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations
Filippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1709-1709
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top